Heart Transplant Rejection drugs in development, 2023

GlobalData tracks 8 drugs in development for Heart Transplant Rejection by seven companies/universities/institutes. The top development phase for Heart Transplant Rejection is preclinical, with five drugs in that stage.

Psych Congress Roundup: Digital Tx for MDD; Esketamine Rooms; PA Contributions

Research presented at this year’s Psych Congress meeting in Boston included a randomized trial of esketamine (Spravato) monotherapy, long-term data on xanomeline and trospium chloride

November 7, 2024

Amid backlash to harm reduction, addiction experts warn against reprising ‘war on drugs’

SAN FRANCISCO — Amid what feels like an ever-worsening drug crisis here, locals and politicians alike are fed up. Overdose death rates remain near all-time

May 16, 2024

Research could help drug developers improve the safety profiles of medications

Research from the University of British Columbia, MIT, and the University of Michigan could help drug developers improve the safety profiles of medications and reduce

July 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.